BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34970090)

  • 1. Histopathologic Analysis of Surgically Resected Lungs of Patients with Non-tuberculous Mycobacterial Lung Disease: a Retrospective and Hypothesis-generating Study.
    Choi S; Potts KJ; Althoff MD; Jimenez G; Bai X; Calhoun KM; Cool CD; Chan ED
    Yale J Biol Med; 2021 Dec; 94(4):527-535. PubMed ID: 34970090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.
    Maya TG; Komba EV; Mensah GI; Mbelele PM; Mpagama SG; Mfinanga SG; Addo KK; Kazwala RR
    PLoS One; 2022; 17(3):e0265358. PubMed ID: 35324922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.
    Park S; Jo KW; Lee SD; Kim WS; Shim TS
    Respir Med; 2017 Dec; 133():36-41. PubMed ID: 29173447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causative species of nontuberculous mycobacterial lung disease and comparative investigation on clinical features of Mycobacterium abscessus complex disease: A retrospective analysis for two major hospitals in a subtropical region of Japan.
    Nagano H; Kinjo T; Nei Y; Yamashiro S; Fujita J; Kishaba T
    PLoS One; 2017; 12(10):e0186826. PubMed ID: 29059250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in Germany.
    Steindor M; Hafkemeyer S; Ruckes C; Stehling F; Naehrlich L; Ringshausen FC
    Int J Infect Dis; 2023 Apr; 129():32-39. PubMed ID: 36736578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features and Prognosis of Nontuberculous Mycobacterial Pleuritis: A Multicenter Retrospective Study.
    Yagi K; Ito A; Fujiwara K; Morino E; Hase I; Nakano Y; Asakura T; Furuuchi K; Morita A; Asami T; Namkoong H; Saito F; Morimoto K; Ishii M; Sato Y; Tateno H; Nishio K; Oyamada Y; Fukunaga K; Sugiyama H; Ishida T; Kurashima A; Hasegawa N
    Ann Am Thorac Soc; 2021 Sep; 18(9):1490-1497. PubMed ID: 33832404
    [No Abstract]   [Full Text] [Related]  

  • 8. The Impact of Nontuberculous Mycobacteria Species on Mortality in Patients With Nontuberculous Mycobacterial Lung Disease.
    Wang PH; Pan SW; Wang SM; Shu CC; Chang CH
    Front Microbiol; 2022; 13():909274. PubMed ID: 35875534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiological findings in nontuberculous mycobacterial pulmonary diseases: A comparison between the Mycobacterium avium complex and the Mycobacterium abscessus complex.
    Nagano H; Kinjo T; Fujita J; Kishaba T
    PLoS One; 2022; 17(7):e0271660. PubMed ID: 35862353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.
    Kwon YS; Koh WJ
    J Korean Med Sci; 2016 May; 31(5):649-59. PubMed ID: 27134484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases.
    Yagi K; Ishii M; Namkoong H; Asami T; Iketani O; Asakura T; Suzuki S; Sugiura H; Yamada Y; Nishimura T; Fujiwara H; Funatsu Y; Uwamino Y; Kamo T; Tasaka S; Betsuyaku T; Hasegawa N
    BMC Infect Dis; 2017 Aug; 17(1):558. PubMed ID: 28793869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambaréné, Gabon-a cross-sectional study.
    Ndanga MED; Abdul JBPAA; Edoa JR; Ibinda GARM; Adegbite BR; Mevyann RC; Biyogho CM; Mahoumbou J; Manguinga S; Roguet NM; Lell B; Kremsner PG; Alabi AS; Grobusch MP; Adegnika AA
    BMC Infect Dis; 2023 Oct; 23(1):651. PubMed ID: 37789292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Characteristics of Co-isolation of Multiple Nontuberculous Mycobacteria.
    Asaoka M; Hagiwara E; Etori S; Higa K; Ikeda S; Sekine A; Kitamura H; Baba T; Komatsu S; Ogura T
    Intern Med; 2021 Oct; 60(20):3213-3219. PubMed ID: 33896860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttreatment Lymphopenia Is Associated With an Increased Risk of Redeveloping Nontuberculous Lung Disease in Patients With Mycobacterium avium Complex Lung Disease.
    Furuuchi K; Fujiwara K; Uesgi F; Shimoda M; Seto S; Tanaka Y; Yoshiyama T; Yoshimori K; Kurashima A; Ohta K; Morimoto K
    Clin Infect Dis; 2021 Jul; 73(1):e152-e157. PubMed ID: 32507892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and clinical significance of respiratory isolates of non-tuberculous mycobacteria in Riyadh, Saudi Arabia.
    Al-Harbi A; Al-Jahdali H; Al-Johani S; Baharoon S; Bin Salih S; Khan M
    Clin Respir J; 2016 Mar; 10(2):198-203. PubMed ID: 25130951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis.
    Vande Weygaerde Y; Cardinaels N; Bomans P; Chin T; Boelens J; André E; Van Braeckel E; Lorent N
    BMC Infect Dis; 2019 Dec; 19(1):1061. PubMed ID: 31847834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
    Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
    Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.
    Morimoto K; Hasegawa N; Izumi K; Namkoong H; Uchimura K; Yoshiyama T; Hoshino Y; Kurashima A; Sokunaga J; Shibuya S; Shimojima M; Ato M; Mitarai S
    Ann Am Thorac Soc; 2017 Jan; 14(1):49-56. PubMed ID: 27788025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease.
    Jhun BW; Yang B; Moon SM; Lee H; Park HY; Jeon K; Kwon OJ; Ahn J; Moon IJ; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.